20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Varex Imaging Corp (VREX) operates in the MEDICAL DEVICES industry and is headquartered in Salt Lake City, United States with about 2,500 employees. Its market capitalization is roughly $779 million. In the fiscal year ended 2025-09-30, VREX reported $845M in revenue and ($70M) in net income.
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial.
Interactive charts & full statements → Open the VREX valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $865M | $845M | $811M | $893M | $859M | $818M | $738M | $781M | $773M | $698M | $620M | $632M | $685M | $670M |
| Gross Profit | $297M | $290M | $257M | $290M | $284M | $272M | $190M | $257M | $254M | $254M | $248M | $251M | $279M | $268M |
| Gross Margin % | 34.3% | 34.4% | 31.7% | 32.5% | 33.0% | 33.2% | 25.8% | 32.9% | 32.8% | 36.3% | 40.1% | 39.6% | 40.7% | 40.0% |
| Operating Income (EBIT) | $72M | ($28M) | $32M | $77M | $88M | $74M | ($34M) | $8M | $44M | $84M | $109M | $128M | $176M | $169M |
| Operating Margin % | 8.3% | -3.3% | 4.0% | 8.6% | 10.3% | 9.1% | -4.6% | 1.1% | 5.8% | 12.0% | 17.6% | 20.2% | 25.7% | 25.2% |
| Net Income | $22M | ($70M) | ($48M) | $47M | $30M | $17M | ($58M) | $16M | $28M | $52M | $68M | $80M | $110M | $110M |
| Net Margin % | 2.5% | -8.3% | -5.9% | 5.3% | 3.5% | 2.1% | -7.8% | 2.0% | 3.6% | 7.4% | 11.1% | 12.7% | 16.1% | 16.4% |
| EBITDA | $87M | $4M | $63M | $95M | $114M | $104M | ($9M) | $84M | $90M | $111M | $122M | $141M | $185M | $181M |
| Earnings Per Share (EPS) | $0.52 | $-1.70 | $-1.17 | $0.94 | $0.73 | $0.43 | $-1.49 | $0.40 | $0.72 | $1.36 | $1.78 | $2.08 | $2.87 | $2.85 |
| Shares Outstanding (M) | 43M | 41M | 41M | 50M | 42M | 40M | 39M | 39M | 38M | 38M | 38M | 38M | 38M | 38M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $210M | $216M | $210M | $229M | $203M | $213M | $200M | $206M |
| Gross Profit | $77M | $73M | $70M | $78M | $68M | $77M | $68M | $67M |
| Gross Margin % | 36.4% | 33.6% | 33.3% | 34.0% | 33.2% | 36.0% | 34.3% | 32.6% |
| Operating Income (EBIT) | $23M | $14M | $15M | $20M | ($81M) | $22M | $11M | $11M |
| Operating Margin % | 10.8% | 6.7% | 7.3% | 8.6% | -39.8% | 10.4% | 5.6% | 5.3% |
| Net Income | $16M | ($8M) | $2M | $12M | ($89M) | $7M | $0M | ($50M) |
| Net Margin % | 7.5% | -3.8% | 1.1% | 5.3% | -43.9% | 3.2% | -0.1% | -24.3% |
| EBITDA | $22M | $18M | $18M | $29M | ($71M) | $28M | $18M | $17M |
| Earnings Per Share (EPS) | $0.37 | $-0.19 | $0.05 | $0.29 | $-2.15 | $0.13 | $-0.01 | $-1.23 |
| Shares Outstanding (M) | 43M | 42M | 42M | 42M | 42M | 51M | 41M | 41M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 | 2013-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $11M | $42M | $47M | $108M | $17M | $93M | $13M | $72M | $85M | $75M | $74M | $85M | $119M | $91M |
| Capital Expenditures (CapEx) | $32M | $23M | $27M | $21M | $21M | $15M | $24M | $20M | $20M | $20M | $29M | $34M | $23M | $8M |
| Free Cash Flow (FCF) | ($20M) | $19M | $20M | $88M | ($4M) | $78M | ($10M) | $52M | $65M | $54M | $45M | $51M | $95M | $83M |
| FCF Margin % | -2.3% | 2.2% | 2.5% | 9.8% | -0.5% | 9.5% | -1.4% | 6.7% | 8.4% | 7.8% | 7.3% | 8.1% | 13.9% | 12.4% |
| Dividends Paid | — | — | — | — | $3M | $1M | $53M | $0M | $1M | $227M | $227M | $227M | $227M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $21M | ($2M) | ($16M) | $8M | $8M | $17M | $10M | $26M |
| Capital Expenditures (CapEx) | $9M | $6M | $11M | $6M | $6M | $7M | $4M | $6M |
| Free Cash Flow (FCF) | $12M | ($8M) | ($27M) | $2M | $1M | $10M | $5M | $20M |
| FCF Margin % | 5.7% | -3.6% | -12.8% | 1.0% | 0.7% | 4.6% | 2.6% | 9.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 | 2014-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B | $1.1B | $1.1B | $1.0B | $988M | $1.0B | $622M | $584M | $433M |
| Cash & Cash Equivalents | $99M | $145M | $169M | $153M | $89M | $145M | $101M | $30M | $52M | $83M | $36M | $21M | $0M |
| Total Liabilities | $590M | $621M | $668M | $669M | $638M | $651M | $674M | $581M | $549M | $650M | $86M | $88M | $74M |
| Total Debt (Short + Long-Term) | $352M | $372M | $447M | $446M | $419M | $441M | $462M | $395M | $390M | $484M | $0M | $1M | $0M |
| Total Shareholders' Equity | $497M | $473M | $535M | $568M | $533M | $483M | $452M | $446M | $426M | $379M | $526M | $485M | $359M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VREX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms